EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay

Jessica R Chapman, Jeeyeon Baik, Oana Madalina Mereuta, Sansan Yi, Ayal Cooper Walland, Kristel Flor, Ashley Wooten, Jessica Wardrope, Maria Stella Ritorto, Ahmet Dogan

Molecular & Cellular Proteomics · 2026-01 · 25 (1) · 101487

DOI: 10.1016/j.mcpro.2025.101487 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Molecular & Cellular Proteomics, 2026-01. Verfasst von Jessica R Chapman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: chapmanj@mskcc.org. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry, Pathology, Molecular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Farmer Family Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass spectrometry-based proteomics has been applied to many fields and has made major contributions to our understanding of biology and medicine. Translation of this technology and assays to patient testing has been limited despite grand expectations. The amyloid protein identification by LC-MS test is one successful example of the adaptation of this technology by molecular and clinical pathology laboratories. Through the illustration of this assay, we will address some of these challenges and outline a process for validation and implementation of mass spectrometry-based proteomics in the molecular pathology laboratory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsMass SpectrometryPathology, MolecularHumansChromatography, Liquid

Stichwörter der Autor:innen

FFPE tissueamyloidosisclinicalvalidation

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: chapmanj@mskcc.org.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.

Förderung

  • NCI NIH HHS
  • Farmer Family Foundation
  • National Institutes of Health

Zitieren

APA

Chapman, J. R., Baik, J., Mereuta, O. M., Yi, S., Walland, A. C., Flor, K., Wooten, A., Wardrope, J., Ritorto, M. S., & Dogan, A. (2026). Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay. Molecular & Cellular Proteomics, 25(1), 101487. https://doi.org/10.1016/j.mcpro.2025.101487

Vancouver

Chapman JR, Baik J, Mereuta OM, Yi S, Walland AC, Flor K, et al. Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay. Molecular & Cellular Proteomics. 2026;25(1):101487. doi:10.1016/j.mcpro.2025.101487

BibTeX
@article{Chapman2026,
  author = {Chapman, Jessica R and Baik, Jeeyeon and Mereuta, Oana Madalina and Yi, Sansan and Walland, Ayal Cooper and Flor, Kristel and Wooten, Ashley and Wardrope, Jessica and Ritorto, Maria Stella and Dogan, Ahmet},
  title = {Validation of a Mass Spectrometry–Based Proteomics Molecular Pathology Assay},
  journal = {Molecular & Cellular Proteomics},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {101487},
  doi = {10.1016/j.mcpro.2025.101487}
}
Kostenlos starten →